| 000 | 01315 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516150027.0 | ||
| 264 | 0 | _c20131210 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1499-2752 | ||
| 024 | 7 |
_a10.3899/jrheum.121098 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKahn, Philip J | |
| 245 | 0 | 0 |
_aHigher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cMay 2013 |
||
| 300 |
_a743-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xtherapeutic use |
| 650 | 0 | 4 |
_aMacrophage Activation Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCron, Randy Q | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 40 _gno. 5 _gp. 743-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.121098 _zAvailable from publisher's website |
| 999 |
_c22717833 _d22717833 |
||